The Drug-Induced Respiratory Disease Website
No current undisputable evidence
Publications
Rini BI, Melichar B, Ueda T, Grünwald V, Fishman MN, Arranz JA, Bair AH, Pithavala YK, Andrews GI, Pavlov D, Kim S, Jonasch E
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial.
The Lancet. Oncology 2013 Nov;14;1233-42 — 2013 Nov — 1233-42